501 related articles for article (PubMed ID: 24840856)
1. Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality.
Psutka SP; Carrasco A; Schmit GD; Moynagh MR; Boorjian SA; Frank I; Stewart SB; Thapa P; Tarrell RF; Cheville JC; Tollefson MK
Cancer; 2014 Sep; 120(18):2910-8. PubMed ID: 24840856
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer.
Mayr R; Gierth M; Zeman F; Reiffen M; Seeger P; Wezel F; Pycha A; Comploj E; Bonatti M; Ritter M; van Rhijn BWG; Burger M; Bolenz C; Fritsche HM; Martini T
J Cachexia Sarcopenia Muscle; 2018 Jun; 9(3):505-513. PubMed ID: 29479839
[TBL] [Abstract][Full Text] [Related]
3. Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer.
Boorjian SA; Kim SP; Tollefson MK; Carrasco A; Cheville JC; Thompson RH; Thapa P; Frank I
J Urol; 2013 Jul; 190(1):55-60. PubMed ID: 23313198
[TBL] [Abstract][Full Text] [Related]
4. The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer.
Eisenberg MS; Boorjian SA; Cheville JC; Thompson RH; Thapa P; Kaushik D; Frank I
J Urol; 2013 Dec; 190(6):2005-10. PubMed ID: 23770147
[TBL] [Abstract][Full Text] [Related]
5. Decrease in skeletal muscle index 1 year after radical cystectomy as a prognostic indicator in patients with urothelial bladder cancer.
Ha YS; Kim SW; Kwon TG; Chung SK; Yoo ES
Int Braz J Urol; 2019; 45(4):686-694. PubMed ID: 30901172
[TBL] [Abstract][Full Text] [Related]
6. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.
Linder BJ; Frank I; Cheville JC; Tollefson MK; Thompson RH; Tarrell RF; Thapa P; Boorjian SA
Eur Urol; 2013 May; 63(5):839-45. PubMed ID: 23332883
[TBL] [Abstract][Full Text] [Related]
7. Mortality after radical cystectomy: impact of obesity versus adiposity after adjusting for skeletal muscle wasting.
Psutka SP; Boorjian SA; Moynagh MR; Schmit GD; Frank I; Carrasco A; Stewart SB; Tarrell R; Thapa P; Tollefson MK
J Urol; 2015 May; 193(5):1507-13. PubMed ID: 25464002
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
[TBL] [Abstract][Full Text] [Related]
9. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
May M; Bastian PJ; Brookman-May S; Fritsche HM; Tilki D; Otto W; Bolenz C; Gilfrich C; Trojan L; Herrmann E; Moritz R; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Wieland WF; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M
Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder.
Mayr R; May M; Martini T; Lodde M; Comploj E; Pycha A; Strobel J; Denzinger S; Otto W; Wieland W; Burger M; Fritsche HM
Eur Urol; 2012 Oct; 62(4):662-70. PubMed ID: 22534059
[TBL] [Abstract][Full Text] [Related]
11. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
Evers PD; Logan JE; Sills V; Chin AI
World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder.
Miyake M; Morizawa Y; Hori S; Marugami N; Shimada K; Gotoh D; Tatsumi Y; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Tanaka N; Fujimoto K
BMC Cancer; 2017 Mar; 17(1):237. PubMed ID: 28359307
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenia predicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancer.
Mayr R; Fritsche HM; Zeman F; Reiffen M; Siebertz L; Niessen C; Pycha A; van Rhijn BWG; Burger M; Gierth M
World J Urol; 2018 Aug; 36(8):1201-1207. PubMed ID: 29520591
[TBL] [Abstract][Full Text] [Related]
14. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality?
Abel EJ; Linder BJ; Bauman TM; Bauer RM; Thompson RH; Thapa P; Devon ON; Tarrell RF; Frank I; Jarrard DF; Downs TM; Boorjian SA
Eur Urol; 2014 Dec; 66(6):1139-47. PubMed ID: 25194909
[TBL] [Abstract][Full Text] [Related]
15. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.
Rink M; Zabor EC; Furberg H; Xylinas E; Ehdaie B; Novara G; Babjuk M; Pycha A; Lotan Y; Trinh QD; Chun FK; Lee RK; Karakiewicz PI; Fisch M; Robinson BD; Scherr DS; Shariat SF
Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854
[TBL] [Abstract][Full Text] [Related]
16. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
17. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
[TBL] [Abstract][Full Text] [Related]
18. Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist.
Capitanio U; Isbarn H; Shariat SF; Jeldres C; Zini L; Saad F; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
Urology; 2009 Oct; 74(4):858-64. PubMed ID: 19628260
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and outcomes of urethral recurrence following radical cystectomy.
Boorjian SA; Kim SP; Weight CJ; Cheville JC; Thapa P; Frank I
Eur Urol; 2011 Dec; 60(6):1266-72. PubMed ID: 21871713
[TBL] [Abstract][Full Text] [Related]
20. Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy.
Hirasawa Y; Nakashima J; Yunaiyama D; Sugihara T; Gondo T; Nakagami Y; Horiguchi Y; Ohno Y; Namiki K; Ohori M; Tokuuye K; Tachibana M
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1048-1054. PubMed ID: 27699608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
